Dose Escalation Evaluation
Dose Escalation Evaluation is a methodological framework within pharmacokinetic and pharmacodynamic analysis that systematically assesses the relationship between increasing drug doses and corresponding changes in exposure metrics to determine dose-proportionality during clinical development.
734
Publications
38.1K
Citations
6.8K
Authors
1.7K
Institutions
Publications per year
2017–2026
265
734
Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia
Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas et al. · Journal of Clinical Oncology · 2001 · 588 citations
Pharmacy, Oncology, Pharmacotherapy +17
1–5 of 734
6.8K
19
h-index
The Barbara Ann Karmanos Cancer Institute, United States
20 publications · 1.2K citations
17
h-index
14
h-index
12
h-index
South Texas Accelerated Research Therapeutics, United States
12 publications · 771 citations
12
h-index
1–5 of 6.8K
1.7K
The University of Texas MD Anderson Cancer Center
Houston, United States
37 h-index
224 publications
24.4K citations
Dana-Farber Cancer Institute
Boston, United States
32 h-index
116 publications
11.3K citations
Sarah Cannon
Nashville, United States
28 h-index
132 publications
6.8K citations
Memorial Sloan Kettering Cancer Center
New York, United States
27 h-index
126 publications
5.2K citations
Massachusetts General Hospital
Boston, United States
21 h-index
94 publications
5K citations

Cornell University
Ithaca, United States
20 h-index
78 publications
4.5K citations
Tennessee Oncology
Nashville, United States
20 h-index
66 publications
3.9K citations

Princess Margaret Cancer Centre
Toronto, Canada
19 h-index
65 publications
2.4K citations
1–8 of 1.7K
159 publications · 8.2K citations
44
h-index
46 publications · 4K citations
34
h-index
Repository · 34 publications · 1.2K citations
21
h-index
BJC · 20 publications · 1K citations
16
h-index
18 publications · 668 citations
15
h-index
1–5